03 September, 2017
The institutional investor held 22.54 million shares of the major pharmaceuticals company at the end of 2016Q4, valued at $1.32 billion, up from 71,958 at the end of the previous reported quarter. Shepherd Financial Partners LLC lifted its stake in Bristol-Myers Squibb by 1.6% during the 1st quarter.
Bristol-Myers Squibb (NYSE:BMY) last posted its earnings results on Thursday, July 27th. It has underperformed by 31.22% the S&P500.
Smith Moore & Company increased Bristol Myers Squibb Co (BMY) stake by 46.05% reported in 2016Q4 SEC filing. The Illinois-based Continental Advisors Llc has invested 1.3% in the stock. Columbia Partners Llc Investment Management who had been investing in Bristol Myers Squibb for a number of months, seems to be less bullish one the $98.23 billion market cap company.
Bristol-Myers Squibb Company (NYSE BMY) traded down 0.96% on Friday, hitting $59.90. S&Co Inc acquired 327,110 shares as Bristol (BMY)'s stock declined 1.04%. It has underperformed by 39.89% the S&P500. Vetr raised Bristol-Myers Squibb from a "buy" rating to a "strong-buy" rating and set a $58.88 price target for the company in a research report on Monday, June 5th. Therefore 32% are positive. Finally, Cowen and Company set a $65.00 price target on Bristol-Myers Squibb and gave the stock a "hold" rating in a research report on Monday, July 10th. Twin Capital Management Inc.'s holdings in Bristol-Myers Squibb were worth $8,839,000 as of its most recent filing with the Securities and Exchange Commission (SEC). The firm has "Equal Weight" rating by Barclays Capital given on Friday, April 29. The company was maintained on Tuesday, March 15 by Jefferies. The stock has "Buy" rating by Cowen & Co on Friday, August 25. Prelude Mgmt Ltd Com holds 0.43% or 429,500 shares.
Since March 3, 2017, it had 0 insider purchases, and 5 selling transactions for $5.32 million activity. 34,000 shares were sold by ANDREOTTI LAMBERTO, worth $1.81M. $463,779 worth of Bristol-Myers Squibb Co (NYSE:BMY) was sold by Caldarella Joseph C on Wednesday, March 15. Canada Pension Plan Investment Board now owns 3,362,609 shares of the biopharmaceutical company's stock worth $182,859,000 after acquiring an additional 646,000 shares during the last quarter. It also reduced its holding in Paypal Holdings Inc by 12,143 shares in the quarter, leaving it with 204,020 shares, and cut its stake in Walt Disney Co/The (NYSE:DIS).
Investors sentiment decreased to 0.95 in Q4 2016. Its down 0.46, from 1.24 in 2016Q3. 126 funds opened positions while 468 raised stakes. Bartlett & Co Limited holds 1.4% or 508,045 shares in its portfolio. Tarbox Grp Inc holds 71 shares or 0% of its portfolio. Natixis reported 0.18% in Bristol-Myers Squibb Co (NYSE:BMY). Moreover, Atlantic Trust Group Ltd Liability has 0.15% invested in Bristol-Myers Squibb Co (NYSE:BMY) for 389,523 shares. Wealthtrust Fairport Ltd Liability Corporation invested in 0.03% or 4,257 shares. Bessemer Group Inc Inc holds 3.27M shares. State Treasurer State Of Michigan accumulated 140,161 shares. Exane Derivatives holds 0% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY) for 1,770 shares. Philadelphia Tru Company holds 0.09% or 20,924 shares in its portfolio. Stevens First Principles Invest Advsrs reported 777 shares. Silvercrest Asset Gru Limited Liability Com has 219,970 shares for 0.14% of their portfolio. Noesis Capital Mangement holds 5,538 shares. Moreover, Nuveen Asset Mngmt Limited Liability Corp has 0.06% invested in Bristol-Myers Squibb Co (NYSE:BMY) for 217,258 shares. Therefore 18% are positive. Eli Lilly and Company had 70 analyst reports since July 23, 2015 according to SRatingsIntel. The rating was maintained by Jefferies on Wednesday, August 23 with "Buy". Seaport Global upgraded it to "Hold" rating and $2600 target in Friday, August 11 report. On Wednesday, August 23 the stock rating was maintained by Jefferies with "Buy". On Thursday, October 29 the stock rating was downgraded by Goldman Sachs to "Neutral". The company was initiated on Friday, October 7 by Goldman Sachs. RBC Capital Markets maintained Noble Energy, Inc. The stock has "Hold" rating by Evercore on Wednesday, January 6. The firm has "Buy" rating given on Friday, April 29 by UBS.
Investors sentiment decreased to 1.1 in Q4 2016. Its down 0.03, from 0.98 in 2016Q3. It fall, as 84 investors sold LLY shares while 380 reduced holdings. Da Davidson Co stated it has 37,086 shares. Visionary Asset holds 1.09% of its portfolio in Eli Lilly and Co (NYSE:LLY) for 45,655 shares. The British Columbia - Canada-based British Columbia Management Corporation has invested 0.29% in Eli Lilly and Co (NYSE:LLY). 94,931 were reported by Farmers And Merchants Invests Incorporated. The biopharmaceutical company reported $0.74 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.73 by $0.01. Following the completion of the purchase, the director now owns 18,000 shares in the company, valued at approximately $1,006,920. Westpac Corp stated it has 0% in Bristol-Myers Squibb Co (NYSE:BMY). Dubuque National Bank And Com has invested 0.01% in Eli Lilly and Co (NYSE:LLY).
